Genertec Universal Medical Group Company Limited Capital Reinvestment Ratio
Genertec Universal Medical Group Company Limited capital reinvestment ratio. Genertec Universal Medical Group Company Limited (5UM) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.69 Billion) in capital expenditures (€170.49 Million). Check Genertec Universal Medical Group Company (5UM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genertec Universal Medical Group Company Limited (2022–2025)
Capital reinvestment ratio of Genertec Universal Medical Group Company Limited from 2022 to 2025. This chart tracks Genertec Universal Medical Group Company Limited's Capital Reinvestment Ratio across 4 annual periods. Also explore Genertec Universal Medical Group Company equity growth rate to track the company's year-over-year net asset growth rate.
Genertec Universal Medical Group Company Limited Capital Reinvestment Ratio by Year (2022–2025)
Genertec Universal Medical Group Company Limited capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see Genertec Universal Medical Group Company operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | €5.78 Billion | €988.91 Million | ▼ -84.5% |
| 2024 | 1.10x | €1.14 Billion | €1.26 Billion | ▲ +514.0% |
| 2023 | 0.18x | €4.99 Billion | €896.83 Million | ▼ -39.2% |
| 2022 | 0.30x | €2.06 Billion | €608.09 Million | — |